Actavis PLC and Forest Laboratories Inc. have agreed to sell or relinquish their rights to four generic pharmaceuticals to settle antitrust concerns stemming from their planned merger.. The proposed settlement with the Federal Trade Commission is part of the agency's push to preserve competition and curb health-care costs.. According to the FTC...
  